Assessment Of A Race-Based Pharmaceutical Drug
BiDil: Assessing a Race-Based Pharmaceutical
By Howard Brody, M.D., Ph.D., et al
----------------------------
Article adapted by Start Sanatate from original press release.
----------------------------
Annals of Family Medicine is a peer-reviewed, indexed research journal that provides a cross-disciplinary forum for new, evidence-based information affecting the primary care disciplines. Annals is sponsored by six family medical organizations, including the American Academy of Family Physicians, the American Board of Family Medicine, the Society of Teachers of Family Medicine, the Association of Departments of Family Medicine, the Association of Family Medicine Residency Directors and the North American Primary Care Research Group. Annals is published six times each year and contains original research from the clinical, biomedical, social and health services areas, as well as contributions on methodology and theory, selected reviews, essays and editorials. Complete editorial content and interactive discussion groups for each published article can be accessed free of charge on the journal's Web site, http://www.annfammed.org/.
Contact: Kristin Robinson
American Academy of Family Physicians
View drug information on BiDil.
O rasã de evaluare pe baza de droguri farmaceutice - Assessment Of A Race-Based Pharmaceutical Drug - articole medicale engleza - startsanatate